Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin-induced TFPI release in lacunar stroke and white matter lesions
NL-OMON28742Active, not recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Oct 2008
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of heparin in lacunar infarct (3 arms), sponsored by Maastricht University Medical Center+. Primary endpoints: Plasma TFPI concentration before and after heparin in controls and lacunar stroke patients, Difference in heparin-induced TFPI release between lacunar stroke patients and healthy controls and 1 more. Started Oct 2008; status: active, not recruiting.
02
Drugs
heparin
03
Conditions
lacunar infarct
Beyond the preview
Go deeper on NL-OMON28742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28742.